New compound added to Basilea’s clinical pipeline; upon successful completion of preclinical profiling, start of phase 2 study planned for H1 2025Upfront.
New compound added to Basilea’s clinical pipeline; upon successful completion of preclinical profiling, start of phase 2 study planned for H1 2025Upfront payments of USD 2 million Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, October 19, 2023 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that it has entered into an asset pur
Basilea reports new data for ceftobiprole (Zevtera®) presented at US IDWeek Congress 2023 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Data Bridge Market Research conducted a recent market intelligence study, thoroughly analysing the Sialolithiasis Treatment Market. The newly published report employs an appealing layout that presents essential data using visually engaging tables, graphs, charts, and figures.The Sialolithiasis Treatment market docum.
Methicillin Resistant Staphylococcus Aureus (MRSA) Drugs Market Size, Share, Statistics, Trends And Drivers einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.